secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001193125-26-015346
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics prices $15M public offering of 39.5M units at $0.38; net ~$13.3M
--------------------------------------------------------------------------------

- Offering of 39,473,684 units at $0.38 each, each unit = one share + one warrant.
- Gross proceeds $15M; net proceeds ~$13.3M after underwriting discounts and expenses.
- Underwriter exercised over-allotment for additional 5,921,052 warrants.
- Warrants immediately exercisable at $0.38 per share, expire in 5 years.
- Proceeds for working capital; 45-day insiders lock-up and 120-day ban on variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526015346/0001193125-26-015346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312526015346/d65677d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-015346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer